Drug induced rhabdomyolysis: case report

Area of Science:

• Toxicology
• Nephrology
• Muscle Physiology

Background:

• Rhabdomyolysis is characterized by skeletal muscle breakdown and release of intracellular components into circulation.
• Diverse etiologies include trauma, metabolic disorders, infections, and exposure to drugs and toxins.
• Substance abuse and genetic metabolic disorders are recognized risk factors for rhabdomyolysis.

Observation:

• A case report details rhabdomyolysis in a patient with documented exposure to opiates and benzodiazepines.
• The condition was complicated by acute renal failure, necessitating medical intervention.
• The patient experienced a complete recovery from both rhabdomyolysis and acute renal failure.

Findings:

• The pathogenesis and treatment of rhabdomyolysis associated with opiate and benzodiazepine use are reviewed.
• This case underscores the potential for severe skeletal muscle injury and subsequent renal complications from substance abuse.
• Early recognition and management are crucial for favorable outcomes in drug-induced rhabdomyolysis.

Implications:

• Clinicians should consider rhabdomyolysis in patients with altered mental status or electrolyte imbalances, especially those with a history of substance abuse.
• Awareness of drug-induced rhabdomyolysis is vital for timely diagnosis and treatment, potentially preventing irreversible kidney damage.
• Further research into the specific mechanisms of opiate and benzodiazepine-induced rhabdomyolysis may improve preventative strategies.